Decellularized Native and Engineered Arterial Scaffolds for Transplantation

More than 570,000 coronary artery bypass grafts are implanted each year, creating an important demand for small-diameter vascular grafts. For patients who lack adequate internal mammary artery or saphenous vein, tissue-engineered arteries may prove useful. However, the time needed to tissue engineer...

Full description

Bibliographic Details
Main Authors: Shannon L. M. Dahl, Jennifer Koh, Vikas Prabhakar, Laura E. Niklason M.D, PH.D.
Format: Article
Language:English
Published: SAGE Publishing 2003-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000003108747136
_version_ 1818605705470410752
author Shannon L. M. Dahl
Jennifer Koh
Vikas Prabhakar
Laura E. Niklason M.D, PH.D.
author_facet Shannon L. M. Dahl
Jennifer Koh
Vikas Prabhakar
Laura E. Niklason M.D, PH.D.
author_sort Shannon L. M. Dahl
collection DOAJ
description More than 570,000 coronary artery bypass grafts are implanted each year, creating an important demand for small-diameter vascular grafts. For patients who lack adequate internal mammary artery or saphenous vein, tissue-engineered arteries may prove useful. However, the time needed to tissue engineer arteries (7 weeks or more) is too long for many patients. Decellularized cadaveric human arteries are another possible source of vascular conduit, but limited availability and the potential for disease transmission limit their widespread use. In contrast, decellularized tissue-engineered arteries could serve as grafts for immediate implantation, as scaffolds onto which patients' cells could be seeded, or as carriers for genetically engineered cells to aid cell transplantation. The goal of this study was to quantify the effects of decellularization on vascular matrix and mechanical properties. Specifically, we compared cellular elimination, extracellular matrix retention, and mechanical characteristics of porcine carotid arteries before and after treatment with three decellularization methods. In addition, for the first time, tissue-engineered arteries were decellularized. Decellularized native arteries were also used as a scaffold onto which vascular cells were seeded. These studies identified a decellularization method for native and engineered arteries that maximized cellular elimination, without greatly compromising mechanical integrity. We showed that engineered tissues could be decellularized, and demonstrated the feasibility of reseeding decellularized vessels with vascular cells.
first_indexed 2024-12-16T13:59:12Z
format Article
id doaj.art-ed5737b61d1e4043af8ae89ed37d1d36
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-16T13:59:12Z
publishDate 2003-09-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-ed5737b61d1e4043af8ae89ed37d1d362022-12-21T22:29:08ZengSAGE PublishingCell Transplantation0963-68971555-38922003-09-011210.3727/000000003108747136Decellularized Native and Engineered Arterial Scaffolds for TransplantationShannon L. M. Dahl0Jennifer Koh1Vikas Prabhakar2Laura E. Niklason M.D, PH.D.3 Departments of Biomedical Engineering, Durham, NC 27708Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, MA 02139 Anesthesiology, Duke University, Durham, NC 27708More than 570,000 coronary artery bypass grafts are implanted each year, creating an important demand for small-diameter vascular grafts. For patients who lack adequate internal mammary artery or saphenous vein, tissue-engineered arteries may prove useful. However, the time needed to tissue engineer arteries (7 weeks or more) is too long for many patients. Decellularized cadaveric human arteries are another possible source of vascular conduit, but limited availability and the potential for disease transmission limit their widespread use. In contrast, decellularized tissue-engineered arteries could serve as grafts for immediate implantation, as scaffolds onto which patients' cells could be seeded, or as carriers for genetically engineered cells to aid cell transplantation. The goal of this study was to quantify the effects of decellularization on vascular matrix and mechanical properties. Specifically, we compared cellular elimination, extracellular matrix retention, and mechanical characteristics of porcine carotid arteries before and after treatment with three decellularization methods. In addition, for the first time, tissue-engineered arteries were decellularized. Decellularized native arteries were also used as a scaffold onto which vascular cells were seeded. These studies identified a decellularization method for native and engineered arteries that maximized cellular elimination, without greatly compromising mechanical integrity. We showed that engineered tissues could be decellularized, and demonstrated the feasibility of reseeding decellularized vessels with vascular cells.https://doi.org/10.3727/000000003108747136
spellingShingle Shannon L. M. Dahl
Jennifer Koh
Vikas Prabhakar
Laura E. Niklason M.D, PH.D.
Decellularized Native and Engineered Arterial Scaffolds for Transplantation
Cell Transplantation
title Decellularized Native and Engineered Arterial Scaffolds for Transplantation
title_full Decellularized Native and Engineered Arterial Scaffolds for Transplantation
title_fullStr Decellularized Native and Engineered Arterial Scaffolds for Transplantation
title_full_unstemmed Decellularized Native and Engineered Arterial Scaffolds for Transplantation
title_short Decellularized Native and Engineered Arterial Scaffolds for Transplantation
title_sort decellularized native and engineered arterial scaffolds for transplantation
url https://doi.org/10.3727/000000003108747136
work_keys_str_mv AT shannonlmdahl decellularizednativeandengineeredarterialscaffoldsfortransplantation
AT jenniferkoh decellularizednativeandengineeredarterialscaffoldsfortransplantation
AT vikasprabhakar decellularizednativeandengineeredarterialscaffoldsfortransplantation
AT lauraeniklasonmdphd decellularizednativeandengineeredarterialscaffoldsfortransplantation